Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Effects of Exercise-Induced Muscle Damage on Neuromuscular Complexity (EIMD-NMC)

27 de abril de 2026 actualizado por: Vassilis Paschalis, National and Kapodistrian University of Athens

Effects of Exercise-Induced Muscle Damage Induced by Eccentric Exercise on Knee Extensor Torque, Oxygenation, and Electromyographic Properties: A Complexity-Based Approach

This study will examine the effects of exercise-induced muscle damage, induced by eccentric exercise, on torque production, muscle oxygenation, and electromyographic activity of the knee extensors in healthy young men. Eleven participants will perform a sustained submaximal isometric contraction before and 48 hours after a muscle-damaging eccentric exercise protocol. It is anticipated that the eccentric exercise will confirm the presence of muscle damage, by decrease in maximal voluntary isometric torque, increase in muscle soreness, and reduction in pain-free range of motion. The effect of eccentric exercise on the complexity of torque output, which could be reflected by decreased Sample Entropy and increased DFA α, will be indicated by a possible shift toward more predictable and less adaptable motor control patterns. Based on these results, the investigators will know about the effect of eccentric exercise induced muscle damage on neuromuscular efficiency, that is greater neural input could be required to maintain the same mechanical output, as well as increased oxygen consumption in the active muscle.

Descripción general del estudio

Estado

Terminado

Condiciones

Intervención / Tratamiento

Descripción detallada

The present study was designed to investigate the impact of exercise-induced muscle damage , caused by eccentric exercise, on neuromuscular and physiological function of the knee extensor muscles. The research was based on the contemporary theoretical framework of the "loss of complexity," which proposes that physiological signal variability is not merely random noise, but rather an essential characteristic of healthy and adaptable biological systems. According to this approach, greater signal complexity reflects a more flexible and efficient neuromuscular control strategy, whereas reduced complexity indicates impaired adaptability and a more rigid functional state.

A total of eleven healthy young men (N = 11, age 27.8 ± 2.5 years) participated in the study. During the initial session, anthropometric characteristics were recorded and maximal voluntary isometric torque of the knee extensors was measured. The main testing procedure involved a sustained submaximal isometric contraction performed at 50% of maximal voluntary contraction for 60 seconds. During this task, torque output, muscle oxygenation, and electromyographic activity of the vastus lateralis were continuously was recorded in order to assess both mechanical and neuromuscular responses.

Following baseline testing, participants completed a muscle damage induction protocol consisting of five sets of fifteen maximal eccentric contractions performed at an angular velocity of 60°/s. This protocol was designed to induce structural and functional muscle impairment characteristic of exercise induced muscle damage. Forty-eight hours after the intervention, all measurements were repeated to determine the effects of muscle damage on the same variables. Data were processed and analyzed in MATLAB, with statistical significance set at p < .05.

The results are anticipated to confirm the successful induction of muscle damage.

The investigators wanted to show the effect of exercise induced muscle damage on torque complexity through changes in Sample Entropy, and changes on detrended fluctuation analysis exponent, which indicate that torque fluctuations will became more regular, predictable, and less complex.

A possible reduction in complexity it expected to be accompanied by a change in neuromuscular efficiency, meaning that a greater level of neural activation will be needed to produce the same relative mechanical output. A likely explanation is that damage to muscle fibers and sarcomeres would reduce the effectiveness of force transmission, forcing the nervous system to compensate through increased neural drive.

In parallel, it is expected that muscle oxygenation measurements will show increased deoxygenated hemoglobin, indicating higher oxygen extraction and a greater metabolic burden on the remaining functional muscle fibers. This finding would suggest that, after exercise induced muscle damage, fewer intact fibers may be available to share the workload, thereby increasing the relative demand placed on those still functioning effectively.

An additional important observation will be the possible changes in traditional linear variability indices, such as standard deviation and coefficient of variation. This will highlight the limitation of conventional linear measures in detecting subtle but functionally meaningful changes in neuromuscular regulation.

Tipo de estudio

Intervencionista

Inscripción (Actual)

11

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Attica
      • Athens, Attica, Grecia, 17234
        • School of Physical Education and Sport Science

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

Sí

Descripción

Inclusion Criteria:

  • No experience of resistance exercise with heavy loads the past 6 months

Exclusion Criteria:

  • History of lower-limb injury
  • Taking any medication
  • Suffered from any pathological condition
  • Participation in a systematic eccentric exercise program during the previous 6 months

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: No aleatorizado
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Eccentric exercise
All the parameters that was assessed 48 hours post isokinetic eccentric exercise
Isokinetic eccentric exercise consisted of 5 sets of 15 repetitions using the knee extensors. The intensity of the exercise was the maximal voluntary and an interval of 1 minute was applied between sets.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Isokinetic sub maximal exercise
Periodo de tiempo: From enrollment to the end of the treatment at 48 hours
Isokinetic exercise of 60 seconds using the sub maximal intensity of 50% MVC. The knee joint will be set at 90 degrees and the values will be in Nm.
From enrollment to the end of the treatment at 48 hours
Electromyography
Periodo de tiempo: From enrollment to the end of treatment at 48 hours
Continuous recording of EMG during the 60 seconds isometric exercise. Patches will be placed in vastus laterals and the recording will be at 100 Hz
From enrollment to the end of treatment at 48 hours
Muscle oxygenation
Periodo de tiempo: rom enrollment to the end of treatment at 48 hours
Muscle oxygenation measured using near infrared spectroscopy (NIRS) of the knee extensors during the 60 seconds isometric exercise. The main parameters that will be recored are the oxygenated haemoglobin, the deoxygenated haemoglobin, the total haemoglobin and the difference between oxygenated and deoxygenated haemoglobin.
rom enrollment to the end of treatment at 48 hours

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Delayed onset muscle soreness
Periodo de tiempo: From enrollment to the end of treatment at 48 hours
Assessment of subjective pain feeling assessed by palpation of knee extensors muscle belly. The scale was set between 1 (no pain at all) to 10 (extreme pain).
From enrollment to the end of treatment at 48 hours
Range of Motion
Periodo de tiempo: From enrollment to the end of treatment at 48 hours
The angles the knee joint may be flexed without the feeling of any pain. The starting position was set at full extension.
From enrollment to the end of treatment at 48 hours
Peak torque output
Periodo de tiempo: From enrollment to the end of treatment at 48 hours
Isometric peak torque output was assessed at 90 degrees knee joint angle (0 degrees was set at full extension). The assessments was consisted of 3 set of 5 seconds each. The higher performance was recorded for the data analysis
From enrollment to the end of treatment at 48 hours

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Vassilis Paschalis, Dr., National and Kapodistrian Univesity of Athens

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

20 de agosto de 2025

Finalización primaria (Actual)

20 de enero de 2026

Finalización del estudio (Actual)

30 de marzo de 2026

Fechas de registro del estudio

Enviado por primera vez

19 de abril de 2026

Primero enviado que cumplió con los criterios de control de calidad

27 de abril de 2026

Publicado por primera vez (Actual)

4 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

4 de mayo de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

27 de abril de 2026

Última verificación

1 de abril de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 1731/19-12-2024

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Individual Participant Data (IPD) will not be shared with other researchers in order to protect participant confidentiality and privacy, and because no data-sharing plan was included in the study protocol or consent process.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .